Skip to main content

Biomedical Applications of Radioactive ion Beams

Project description

Improving the applicability of cancer radiotherapy

Charged particle therapy (CPT) using accelerated protons or heavy ions offers certain advantages compared to standard cancer radiotherapy using X-rays. However, issues regarding range uncertainty and poor image guidance limit the widespread applicability of CPT in cancer therapy. The EU-funded BARB project aims to address this problem by employing high-intensity radioactive ion beams that will enable the treatment of small lesions with unprecedented precision. In addition, to facilitate simultaneous treatment and visualisation, scientists will develop an innovative hybrid detector that combines positron emission tomography (PET) and gamma ray imaging. Considering that nearly 50 % of cancer cases undertake radiotherapy treatment, this optimised CPT approach will improve treatment outcome in a significant number of patients.

Call for proposal

ERC-2019-ADG
See other projects for this call

Funding Scheme

ERC-ADG - Advanced Grant

Host institution

GSI HELMHOLTZZENTRUM FUER SCHWERIONENFORSCHUNG GMBH
Address
Planckstrasse 1
64291 Darmstadt
Germany
Activity type
Other
EU contribution
€ 2 000 000

Beneficiaries (2)

GSI HELMHOLTZZENTRUM FUER SCHWERIONENFORSCHUNG GMBH
Germany
EU contribution
€ 2 000 000
Address
Planckstrasse 1
64291 Darmstadt
Activity type
Other
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Germany
EU contribution
€ 500 000
Address
Geschwister Scholl Platz 1
80539 Muenchen
Activity type
Higher or Secondary Education Establishments